help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 27, 2005
Molecular Endocrinology, doi:10.1210/me.2004-0410
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
19/5/1263    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galet, C.
Right arrow Articles by Ascoli, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galet, C.
Right arrow Articles by Ascoli, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*CHORIONIC GONADOTROPIN

Submitted on October 13, 2004
Accepted on January 19, 2005

The differential binding affinities of the lutropin/choriogonadotropin receptor (LHR) for lutropin (LH) and choriogonadotropin (CG) are dictated by different extracellular domain residues

Colette Galet and Mario Ascoli*

Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine The University of Iowa, Iowa City, Iowa 52242-1109

* To whom correspondence should be addressed. E-mail: mario-ascoli{at}uiowa.edu.

The high degree of amino acid sequence homology and the divergent ligand binding affinities of the rat (r) and human (h) lutropin receptors (LHR) allowed us to identify amino acid residues of its extracellular domain that are responsible for the different binding affinities of bovine (b) and human lutropin (LH), and human choriogonadotropin (hCG) to the hLHR and rLHR.

Because of the proposed importance of the {beta}-sheets of the leucine rich repeats (LRRs) of the extracellular domain of the LHR on hormone binding, we examined ten divergent residues present in these regions by analyzing two complementary sets of mutants in which hLHR residues were substituted with the corresponding rLHR residues and vice versa. These experiments resulted in the identification of a single residue (a Ile or Ser in the C-terminal end of LRR2 of the hLHR or rLHR, respectively) that is important for hLH binding affinity. Surprisingly, however, this residue does not affect hCG or for bLH binding affinity. In fact, the results obtained with bLH and hCG show that several of the divergent residues in the {beta}-sheets of LRR1-9 affect bLH binding affinity but none of them affect hCG binding affinity. Importantly, our results also emphasize the involvement of residues outside of the {beta}-sheets of the LRRs of the LHR in ligand binding affinity. This finding has to be considered in future models of the interaction of LH/CG with the LHR.




This article has been cited by other articles:


Home page
FASEB J.Home page
G. Kleinau, H. Jaeschke, S. Mueller, B. M. Raaka, S. Neumann, R. Paschke, and G. Krause
Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor
FASEB J, August 1, 2008; 22(8): 2798 - 2808.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. J. Scott, T. N. Wilkinson, S. Zhang, T. Ferraro, J. D. Wade, G. W. Tregear, and R. A. D. Bathgate
Defining the LGR8 Residues Involved in Binding Insulin-Like Peptide 3
Mol. Endocrinol., July 1, 2007; 21(7): 1699 - 1712.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society